Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineStem CellsHodgkin DiseaseGranulocytesDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateWhole-Body IrradiationTime FactorsInfectionSurvival AnalysisLymphoma, T-CellDoxorubicinPlatelet CountHistocompatibilityPOEMS SyndromePrednisoneCarboplatinHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteDexamethasoneTransplantation, IsogeneicRecombinant ProteinsVidarabineBlood Cell CountFollow-Up StudiesLeukemiaBone Marrow PurgingBlood Transfusion, AutologousAntineoplastic AgentsBlood CellsLymphomaProspective StudiesCytomegalovirus InfectionsFeasibility StudiesFatal OutcomeGraft vs Leukemia EffectMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLiver TransplantationBone MarrowLeukocytes, MononuclearHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellHLA AntigensLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-LymphomaBlood DonorsPrognosisCyclosporineCell SeparationBreast NeoplasmsImmunosuppression